UPDATED Jul 23, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
286Aidigong Maternal & Child Health | HK$0.43 | -8.5% | -66.1% | HK$1.9b | n/a | PE352.5x | E55.7% | 0% | ||
2216Broncus Holding | HK$2.62 | -0.4% | n/a | HK$1.4b | HK$10.32 | PS16.1x | E111.5% | n/a | ||
6669Acotec Scientific Holdings | HK$8.60 | 8.7% | n/a | HK$2.7b | HK$10.99 | PS7.6x | E74.9% | n/a | ||
6609Shanghai HeartCare Medical Technology | HK$32.60 | -0.3% | n/a | HK$1.3b | HK$100.07 | PS12x | E76.1% | n/a | ||
3600Modern Dental Group | HK$2.75 | 0.7% | -60.8% | HK$2.6b | HK$6.23 | PE7.3x | E20.4% | 4.3% | ||
1846EuroEyes International Eye Clinic | HK$5.92 | -11.6% | -55.9% | HK$2.0b | HK$13.40 | PE14.8x | E21.8% | 1.7% | ||
9960Kindstar Globalgene Technology | HK$2.45 | 4.7% | -69.5% | HK$2.4b | HK$3.56 | PS2.3x | E118.5% | n/a | ||
2251Beijing Airdoc Technology | HK$16.40 | -3.0% | n/a | HK$1.7b | HK$47.64 | PS12.7x | E35.4% | n/a | ||
2120Wenzhou Kangning Hospital | HK$12.10 | 0% | -75.8% | HK$872.9m | HK$29.19 | PE9.7x | E17.0% | 0% | ||
2170Suzhou Basecare Medical | HK$4.20 | -3.4% | -79.4% | HK$1.1b | HK$9.33 | PS9.2x | E56.4% | n/a | ||
1612Vincent Medical Holdings | HK$0.67 | 1.5% | -60.8% | HK$437.7m | HK$1.30 | PE7.2x | E4.6% | 7.5% |